NCT01701518View on ClinicalTrials.gov

A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal Membranes

NAUnknownINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

December 31, 2016

Conditions

Epiretinal MembraneMacular Edema

Interventions

DRUG

Ozurdex

biodegradable 0.7mg dexamethasone implant

Trial Locations (2)

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

M5C 2T2

RECRUITING

St. Michael's Hospital, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Unity Health Toronto

OTHER

collaborator

Allergan

INDUSTRY

lead

Sunnybrook Health Sciences Centre

OTHER